The 20 Best Hereditary Neuroblastoma Doctors Near Me in Virginia, US

. Dr. Musgrave is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 50 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Thrombocytopenia, Neuroendocrine Tumor, and Angiosarcoma. Dr. Musgrave is board certified in American Board Of Internal Medicine.

Julie Hallanger is an Endocrinologist practicing medicine in Virginia Beach, Virginia. Dr. Hallanger is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 52 other conditions, according to our data. Her clinical expertise encompasses Thyroid Nodule, Thyroid Cancer, Adrenocortical Carcinoma, Follicular Thyroid Cancer, and Thyroidectomy.

Howard Harrison is an Endocrinologist practicing medicine in Virginia Beach, Virginia. Dr. Harrison is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Thyroid Storm, Toxic Nodular Goiter, Thyroid Nodule, and Hereditary Neuroblastoma.

Oksana Hamidi is an Endocrinologist practicing medicine in Virginia Beach, Virginia. Dr. Hamidi is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 62 other conditions, according to our data. Her clinical expertise encompasses Cushing's syndrome, Addison's Disease, Pheochromocytoma, Hormone Replacement Therapy (HRT), and Liver Embolization.

William Grosh is an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Grosh is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Melanoma, Osteosarcoma, Neuroendocrine Tumor, and Bone Tumor.

Mather Director, Radiation Oncology Research Inova Radiation Oncology Inova Schar CancerDr. Avani Rao is a specialty care physician board certified in radiation oncology who serves as the Director of Research, Proton Therapy Fellowship Director and lead physician in pediatric radiation oncology. She joined Radiation Oncology Associates in 2020. Her areas of interest are pediatric, gynecologic, gastrointestinal and breast malignancies.Dr. Rao graduated from Yale University magna cum laude with a bachelor’s degree in molecular, cellular and developmental biology. She completed medical school, her internal medicine internship and her radiation oncology residency at Johns Hopkins School of Medicine. She was nominated to Alpha Omega Alpha during medical school, and during her residency, Dr. Rao served as Chief Resident. She pursued additional fellowship training at the University of Maryland to gain specific expertise in proton therapy. Dr. Rao has received several awards supporting her research and recognizing her clinical excellence and has published more than 40 peer-reviewed publications. Dr. Rao is board certified in radiation oncology. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Metastatic Brain Tumor, and Prostate Cancer.

Dr. Deeken joined Inova in 2013 and has more than 21 years of clinical experience in internal medicine and medical oncology. He serves as the President of Inova Schar Cancer Institute and Medical Director for the Inova Schar Head and Neck Cancer Program. His clinical research focuses on the use of immunotherapy treatments while his laboratory research takes a closer look at understanding the growing epidemic of head and neck cancers caused by HPV. This includes understanding the tumor mutations that are induced by HPV infection and how those tumors can be better treated with targeted therapies. He believes that gaining a better understanding of genomic factors may explain who might be at risk for developing HPV-caused head and neck cancer. Dr. Deeken served on the national Head and Neck Cancer Scientific Committee for the American Society of Clinical Oncology (ASCO) and currently serves on ASCO's Government Relations Committee. Prior to joining Inova, he was Director of the Head and Neck Medical Oncology Program at the Lombardi Comprehensive Cancer Center at Georgetown University and Regional Director for Medical Oncology for MedStar Health. He currently serves as Professor of Medicine at the University of Virginia. Dr. Deeken received his Doctor of Medicine from Georgetown University, where he also did his residency in internal Medicine. He did his fellowship training in medical oncology at the National Cancer Institute. A native of Wisconsin, Dr. Deeken is married and has 4 children. Dr. Deeken is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, and Oral Squamous Cell Carcinoma.

"Dr. Timothy Cannon is Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova. He is a specialty care physician board certified in medical oncology. He has a special interest in management of gastrointestinal malignancies.Dr. Cannon is the clinical director and moderator of the weekly molecular tumor board at Inova, which matches patients with targeted therapies based on molecular diagnostics. He is very interested in national cooperative group clinical trials and is a member of the NRG colorectal and non-colorectal clinical trials committee. He is the site principal investigator for multiple clinical trials in immunotherapy.Dr. Cannon is chair-elect of the steering committee for the TAPUR trial, which is the largest oncology basket trial in North America. He also served as the chief fellow of hematology/oncology at New York University (NYU). Dr. Cannon was voted fellow of the year at NYU during each of his last two years there. He received a ""best doctor"" award by Northern Virginia magazine in 2015.A native of New Jersey, Dr. Cannon is married with two sons. His wife, Amy, works for Save the Children. In his spare time, he likes to play sports (particularly soccer, flag football, tennis) and read books. He was a member of two Division I basketball teams (University of Utah as a freshman and then later at Brigham Young University) in the 1990s and continues to be a huge basketball fan.". Dr. Cannon is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Dr. Kevin Choe is a specialty care physician board certified in radiation oncology at Inova Health System. He joined Inova in 2015 and has been practicing since 2005. Prior to joining Inova, Dr. Choe was on the faculty at University of Texas, Southwestern Medical Center in Dallas, TX, where he specialized in high-precision stereotactic radiotherapy. His research focused on elucidating the genetic alterations that contribute to cancer development and progression. He also designed and conducted clinical trials, investigating novel strategies to overcome treatment resistance in aggressive and metastatic cancers. Dr. Choe grew up in Fairfax, VA, and appreciates the opportunity to serve the community he cares deeply for. Dr. Choe is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Metastatic Brain Tumor, and Posterior Fossa Tumor.

Dr. Daniel Kim is a specialty care physician board certified in radiation oncology at Inova Health System. Dr. Kim graduated top of his class from Amherst College with degrees in neuroscience and music, while becoming a four-time All-American tennis athlete and winning the NCAA men’s tennis championship. He graduated with his MD and MBA, with honors, from Harvard. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, Meningioma, and Prostatectomy.

Dr. Lonika Majithia is currently the Medical Director of Brachytherapy and Director of Educational Programs at Radiation Oncology Associates, and is board certified in radiation oncology. She joined Radiation Oncology Associates in 2016. Her clinical interests include gynecologic, breast, CNS, GI, thoracic and hematologic malignancies. Dr. Majithia is experienced with multiple radiotherapy techniques including volumetric modulated arc therapies (VMAT), intensity modulated radiation therapy (IMRT), stereotactic body radiotherapy, Gamma Knife and CyberKnife Radiosurgery, intra-operative radiotherapy (IORT), eye plaque brachytherapy, and prostate and gynecologic brachytherapy, including High Dose Rate (HDR) brachytherapy. Dr. Majithia grew up in Albuquerque, NM. She graduated magna cum laude from the University of New Mexico with dual bachelor’s degrees in biology and physics. She was awarded the UNM Merit Scholarship and actively participated in physics and basic science research. She completed her medical training at the University of New Mexico where she was elected to the Alpha Omega Alpha Medical Honor Society. She completed her preliminary medicine internship at the Medical College of Wisconsin in Milwaukee, WI and her radiation oncology residency at The Ohio State University in Columbus, OH. She served as Chief Resident during her last year of residency and remained active in academic pursuits including research and medical education. During her residency, she presented multiple abstracts and presentations at the American Society for Radiation Oncology (ASTRO) annual meetings and American Society of Clinical Oncology (ASCO) meetings. She has published book chapters, written retrospective review articles, and assisted in the development of a phase I clinical trial in hematologic malignancies. During her residency, she also completed a master’s degree in medical sciences. Dr. Majithia is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Metastatic Brain Tumor, Neuroendocrine Carcinoma of the Cervix, and Cervical Cancer.

Mather Chair, Radiation Oncology Department Chair and System Division Chief, Inova Radiation Oncology Inova Schar CancerDr. Ashish Chawla is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2011.He received his undergraduate degree from Pennsylvania State University, graduating with honors in biology. He received his medical degree from Thomas Jefferson University in Philadelphia in 1998, where he was elected to the prestigious Alpha Omega Alpha Medical Honor Society. He completed his radiation oncology training at Harvard’s Massachusetts General Hospital in 2003. There, he won awards for scholarly research as a radiation oncology resident. He has published several peer-reviewed articles related to breast, prostate and gastrointestinal cancer management.Prior to joining Radiation Oncology Associates, he served as a radiation oncologist at Anne Arundel Medical Center in Annapolis, MD. There, he helped lead innovative clinical research as the principal investigator for breast cancer protocols with the Radiation Therapy Oncology Group. He also helped lead the cancer center’s stereotactic radiosurgery program and served as cancer liaison for the American College of Surgeons’ Commission on Cancer. He led numerous studies involving partial breast irradiation as well as prostate, central nervous system, and head and neck cancer investigations.Dr. Chawla’s clinical interests include the multidisciplinary management of breast cancer and prostate cancer patients, and he is the Director of the Partial Breast Irradiation Program at Inova Fairfax Hospital. He has expertise in the use of stereotactic radiosurgery and stereotactic body radiotherapy for tumors of the brain, spine and lung. Additional areas of clinical interest include gastrointestinal, lung, head and neck, and brain tumors.Dr. Chawla has been listed in Washingtonian magazine, Northern Virginia Magazine, and U.S. News and World Report as “Top Doctor” for radiation oncology in the Washington, DC, and Northern Virginia areas. Dr. Chawla is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Familial Prostate Cancer, Prostate Cancer, and Pleuropulmonary Blastoma.

John Feigert is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Feigert is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Familial Colorectal Cancer, Multiple Myeloma, and Chronic Lymphocytic Leukemia (CLL).

Emily Moses is a Hematologist and an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Moses is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Optic Glioma, Glioma, Hereditary Neuroblastoma, and Neuroblastoma.

Daniel Lee Iii is a Hematologist and an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Lee Iii is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Neuroblastoma, Hereditary Neuroblastoma, and Febrile Neutropenia.

Brian Belyea is a Hematologist and an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Belyea is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Rhabdomyosarcoma, Acute Lymphoblastic Leukemia (ALL), Adult Soft Tissue Sarcoma, Hereditary Neuroblastoma, and Tissue Biopsy.

Robert Dreicer is an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Dreicer is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Orchiectomy, and Prostatectomy.

Colleen Druzgal is a Hematologist and an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Druzgal is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her clinical expertise encompasses Hemophilia A, Hemophilia B, Hemophilic Arthropathy, and Acute Lymphoblastic Leukemia (ALL).

Michael Engel is a Hematologist and an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Engel is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Febrile Neutropenia, Beta Thalassemia, and Langerhans Cell Histiocytosis.

Gauri Radkar is an Oncologist practicing medicine in Virginia Beach, Virginia. Dr. Radkar is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 76 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Colorectal Cancer, and Familial Colorectal Cancer.